MMP2 and rheumatoid arthritis: Yu et al. developed dextran sulphate (DS)-based MMP-2 enzyme-sensitive nanomicelles targeting the activated macrophage scavenger receptor class A (SR-A) to improve celastrol (6) bioavailability and efficacy in RA treatment (Table 5) [78].